Together-Breast Cancer Support Platform

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorCedars-Sinai Medical Center

About this trial

The goal of this study is to evaluate the acceptability and engagement of a culturally tailored online peer-support program for Korean speaking breast cancer patients and survivors. The main questions it aims to answer are: 1) Is the peer-support program acceptable and sustainable in terms of engagement between mentors and mentees over a 12-week period? 2) Does participation in the program improve quality of life, psychological well-being (including anxiety and depression), and perceived social support?

Participants will include Korean speaking breast cancer survivors (mentors) and patients currently undergoing treatment (mentees). After enrollment and matching based on screening information, participants will engage in peer-support interactions through an online platform for 12 weeks. Surveys will be administered at baseline, mid-point, post-intervention, and optional 6-month follow-up to assess outcomes.

Eligibility criteria

Qualifiers

Age ≥ 18 years

Self-identify as Korean

Able to read, write, and speak both Korean and English

Diagnosed with breast cancer ≥ 2 years prior to enrollment

Disqualifiers

Individuals who do not meet the inclusion criteria

Individuals unable to use the online platform or required technology

Individuals deemed non-compliant or inappropriate for participation based on investigator judgment (e.g., inability to complete study procedures)

Mentees diagnosed with ductal carcinoma in situ (DCIS)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

24 Participants
are grouped into 2 trial groups

Sponsors and collaborators